| abstract |
The invention provides compounds of formula (I) :-n n or a physiologically acceptable salt or solvate thereof wherein nR¹ represents a halogen or hydrogen atom or a C₁₋₆alkyl or C₁₋₆alkoxy group; nR² represents a phenyl group optionally substituted by one or two substituents; nR³ represents the groupn n R⁴ and R⁵, which may be the same or different, each independently represent a hydrogen atom or a halogen atom, or a group selected from hydroxy, C₁₋₆alkoxy or C₁₋₆alkyl. n The compounds may be used in the treatment or prophylaxis of depression and other CNS disorders. |